Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 11/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 9/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25212405 | 1.00 | ENPP2 (0.50) | ENPP2GRIN2BCYP2D6CYP2C9CYP3A4 | |
| SCHEMBL25210558 | 0.91 | ENPP2 (0.52) | ENPP2GRIN2BCYP2D6CYP2C9CYP3A4 | |
| SCHEMBL30473349 | 0.89 | ENPP2 (0.48) | ENPP2KCNH2 | |
| SCHEMBL25215042 | 0.89 | ENPP2 (0.48) | ENPP2KCNH2 | |
| SCHEMBL25214047 | 0.88 | ENPP2 (0.56) | ENPP2 | |
| SCHEMBL25238927 | 0.82 | ENPP2 (0.51) | ENPP2KCNH2 | |
| SCHEMBL30473340 | 0.81 | GRIN2B (0.54) | ENPP2GRIN2BCYP2D6CYP2C9CYP3A4 | |
| SCHEMBL25213055 | 0.81 | GRIN2B (0.54) | ENPP2GRIN2BCYP2D6CYP2C9CYP3A4 | |
| SCHEMBL25262015 | 0.80 | ENPP2 (0.63) | ENPP2KCNH2 | |
| SCHEMBL25215074 | 0.78 | GRIN2B (0.50) | ENPP2GRIN2BCYP2D6CYP2C9CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023101326-A1 | NOVEL COMPOUND AS AUTOTAXIN INHIBITOR AND USE THEREOF | 주식회사 넥스트젠바이오사이언스 | 2023-06-08 | — | — | WO | claimed |
| WO-2023101326-A1 | NOVEL COMPOUND AS AUTOTAXIN INHIBITOR AND USE THEREOF | 주식회사 넥스트젠바이오사이언스 | 2023-06-08 | — | — | WO | disclosed |